Diferencia entre revisiones de «Template:Typhoid Antibiotics»
Sin resumen de edición |
(Add pediatric Ceftriaxone, Azithromycin, Cefixime dosing) |
||
| (No se muestran 2 ediciones intermedias del mismo usuario) | |||
| Línea 1: | Línea 1: | ||
====Oral therapy with [[Quinolone]] Susceptibility==== | ====Oral therapy with [[Quinolone]] Susceptibility==== | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ciprofloxacin|dose=500-750 mg PO q 12 hrs x 14 days|context=Quinolone Susceptible, Oral}} | ||
====Parenteral Therapy with [[Quinolone]] Susceptibility==== | ====Parenteral Therapy with [[Quinolone]] Susceptibility==== | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ciprofloxacin|dose=400 mg IV q 12 hrs x 10 days|context=Quinolone Susceptible, Parenteral}} | ||
====Parenteral Therapy with [[Quinolone]] Resistance==== | ====Parenteral Therapy with [[Quinolone]] Resistance==== | ||
:''if nalidixic acid resistant, assume [[fluoroquinolone]] resistant'' | :''if nalidixic acid resistant, assume [[fluoroquinolone]] resistant'' | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ceftriaxone|dose=2g IV q 24 hrs x 14 days|context=Quinolone Resistant, Parenteral}} | ||
::'''OR''' | ::'''OR''' | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Cefixime|dose=10-15 mg/kg IV q 12 hrs x 8 days|context=Quinolone Resistant, Parenteral}} | ||
====Oral Therapy with [[Quinolone]] Resistance==== | |||
*{{AntibioticDose|disease=Typhoid fever|drug=Azithromycin|dose=1 g PO daily x 5 days|context=Quinolone Resistant, Oral}} | |||
*{{AntibioticDose|drug=Amoxicillin|dose=''Not 1st line treatment''; 50-100mg/kg/day PO divided q6-8h x 14 days; First Dose: 12.5mg-33.3mg/kg PO x 1|context=Typhoid Fever|disease=Typhoid fever|population=Adult}} | |||
*{{AntibioticDose|drug=Amoxicillin|dose=''Not 1st line treatment''; 50-100mg/kg/day PO divided q6-8h x 14 days|context=Typhoid Fever (>3mo)|disease=Typhoid fever|population=Pediatric}} | |||
==== | ====Pediatric==== | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ceftriaxone|dose=50-80mg/kg IV daily x 10-14 days (max 2g)|context=Pediatric, Quinolone Resistant|population=Pediatric}} | ||
*{{AntibioticDose|disease=Typhoid fever|drug=Azithromycin|dose=10-20mg/kg PO daily x 5-7 days (max 1g)|context=Pediatric, Oral|population=Pediatric}} | |||
*{{AntibioticDose|disease=Typhoid fever|drug=Cefixime|dose=15-20mg/kg/day PO divided BID x 7-14 days (max 400mg/dose)|context=Pediatric Oral Step-down|population=Pediatric}} | |||
Revisión actual - 13:06 20 mar 2026
Oral therapy with Quinolone Susceptibility
- Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days
Parenteral Therapy with Quinolone Susceptibility
- Ciprofloxacin 400 mg IV q 12 hrs x 10 days
Parenteral Therapy with Quinolone Resistance
- if nalidixic acid resistant, assume fluoroquinolone resistant
- Ceftriaxone 2g IV q 24 hrs x 14 days
- OR
- Cefixime 10-15 mg/kg IV q 12 hrs x 8 days
Oral Therapy with Quinolone Resistance
- Azithromycin 1 g PO daily x 5 days
- Amoxicillin Not 1st line treatment; 50-100mg/kg/day PO divided q6-8h x 14 days; First Dose: 12.5mg-33.3mg/kg PO x 1
- Amoxicillin Not 1st line treatment; 50-100mg/kg/day PO divided q6-8h x 14 days
Pediatric
- Ceftriaxone 50-80mg/kg IV daily x 10-14 days (max 2g)
- Azithromycin 10-20mg/kg PO daily x 5-7 days (max 1g)
- Cefixime 15-20mg/kg/day PO divided BID x 7-14 days (max 400mg/dose)